This is an interesting observation because recent studies have shown that the co-expression of Tim3 and PD-1 on Tregs correlates with not only tumor size and immunosuppression, but that it also directly associates with poor clinical prognosis [44, 45]. The gene discussed is HAVCR2; the disease is neoplasm.